Head and Neck Cancer

  • D. A. Elliott
  • N. Nabavizadeh
  • K. Hiluf
  • J. M. HollandEmail author
Part of the Medical Radiology book series (MEDRAD)


Head and neck radiotherapy is a continuously evolving field. The disease itself has changed with the increase in human papilloma virus (HPV) associated oropharyngeal cancer. With this new disease entity, oncologists are struggling to determine optimal therapy. As radiation oncologists, we are questioning our traditional use of chemotherapy as well as our radiation doses and volumes.


  1. Abidia A, Laden G, Kuhan G et al (2003) The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur J Vasc Endovasc Surg 25:513–518PubMedGoogle Scholar
  2. Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24–35PubMedPubMedCentralGoogle Scholar
  3. Annane D, Depondt J, Aubert P et al (2004) Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol 22:4893–4900PubMedGoogle Scholar
  4. Antonadou D, Pepelassi M, Synodinou M et al (2002) Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 52:739–747PubMedGoogle Scholar
  5. Ares C, Hug EB, Lomax AJ et al (2009) Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Radiat Oncol Biol Phys 75:1111–1118PubMedGoogle Scholar
  6. Battermann JJ, Breur K, Hart GA et al (1981) Observations on pulmonary metastases in patients after single doses and multiple fractions of fast neutrons and cobalt-60 gamma rays. Eur J Cancer 17:539–548PubMedGoogle Scholar
  7. Blom M, Dawidson I, Fernberg JO et al (1996) Acupuncture treatment of patients with radiation-induced xerostomia. Eur J Cancer B Oral Oncol 32b:182–190PubMedGoogle Scholar
  8. Brizel DM, Wasserman TH, Henke M et al (2000) Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18:3339–3345PubMedGoogle Scholar
  9. Buentzel J, Micke O, Adamietz IA et al (2006) Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study. Int J Radiat Oncol Biol Phys 64:684–691PubMedGoogle Scholar
  10. Catton C, O’Sullivan B, Bell R et al (1996) Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 41:67–72PubMedGoogle Scholar
  11. Chan AW, Liebsch LJ, Deschler DG, Adams JA, Vrishali LV, McIntyre JF, Pommier P, Fabian RL, Busse PM (2004) Proton radiotherapy for T4 nasopharyngeal carcinoma. J Clin Oncol 22:5574Google Scholar
  12. Chan A, Adams JA, Weyman E et al (2012) A phase II trial of proton radiation therapy with chemotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 84:S151–S152Google Scholar
  13. Chera BS, Amdur RJ, Tepper J et al (2015) Phase 2 trial of de-intensified chemoradiation therapy for favorable-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 93:976–985PubMedGoogle Scholar
  14. Cho JH, Chung WK, Kang W et al (2008) Manual acupuncture improved quality of life in cancer patients with radiation-induced xerostomia. J Altern Complement Med 14:523–526PubMedGoogle Scholar
  15. Chronowski GM, Garden AS, Morrison WH et al (2012) Unilateral radiotherapy for the treatment of tonsil cancer. Int J Radiat Oncol Biol Phys 83:204–209PubMedGoogle Scholar
  16. Clarke RE, Tenorio LM, Hussey JR et al (2008) Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. Int J Radiat Oncol Biol Phys 72:134–143PubMedGoogle Scholar
  17. Cmelak A, Li S, Marur S, Zhao W, Westra WH, Chung CH, Gillison ML, Gilbert J, Bauman JE, Wagner LI, Ferris RL, Trevarthen DR, Dimitrios Colevas A, Jahagirdar BN, Burtness B (2014) E1308: reduced-dose IMRT in human papillomavirus (HPV)-associated resectable oropharyngeal squamous carcinomas (OPSCC) after clinical complete response (CCR) to induction chemotherapy (IC). J Clin Oncol 32:LBA6006Google Scholar
  18. Cohen EE, Karrison TG, Kocherginsky M et al (2014) Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. J Clin Oncol 32:2735–2743PubMedPubMedCentralGoogle Scholar
  19. Delanian S, Lefaix JL (2002) Radionécrose de l’os mature: connaissance physiopathologique récente motrice d’une thérapeutique médicale innovante. Cancer/Radiothérapie 6:1–9Google Scholar
  20. Delanian S, Balla-Mekias S, Lefaix JL (1999) Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol 17:3283–3290PubMedGoogle Scholar
  21. Delanian S, Chatel C, Porcher R et al (2011) Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase ii trial. Int J Radiat Oncol Biol Phys 80:832–839PubMedGoogle Scholar
  22. Dhanda J, Pasquier D, Newman L et al (2016) Current concepts in osteoradionecrosis after head and neck radiotherapy. Clin Oncol (R Coll Radiol) 28:459–466Google Scholar
  23. Feehan PE, Castro JR, Phillips TL et al (1992) Recurrent locally advanced nasopharyngeal carcinoma treated with heavy charged particle irradiation. Int J Radiat Oncol Biol Phys 23:881–884PubMedGoogle Scholar
  24. Forastiere AA, Zhang Q, Weber RS et al (2013) Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31:845–852PubMedGoogle Scholar
  25. Frank SJ (2016) Intensity modulated proton therapy for head and neck tumors: gilding the lily or holy grail? Int J Radiat Oncol Biol Phys 95:37–39PubMedGoogle Scholar
  26. Gerweck LE, Kozin SV (1999) Relative biological effectiveness of proton beams in clinical therapy. Radiother Oncol 50:135–142PubMedGoogle Scholar
  27. Gillison ML, Koch WM, Capone RB et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709–720PubMedGoogle Scholar
  28. Gothard L, Stanton A, MacLaren J et al (2004) Non-randomised phase ii trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer. Radiother Oncol 70:217–224PubMedGoogle Scholar
  29. Grover S, Swisher-McClure S, Mitra N et al (2015) Total laryngectomy versus larynx preservation for T4a larynx cancer: patterns of care and survival outcomes. Int J Radiat Oncol Biol Phys 92:594–601PubMedGoogle Scholar
  30. Haddad R, Sonis S, Posner M et al (2009) Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer. Cancer 115:4514–4523PubMedGoogle Scholar
  31. Haddad R, O’Neill A, Rabinowits G et al (2013) Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (paradigm): a randomised phase 3 trial. Lancet Oncol 14:257–264PubMedGoogle Scholar
  32. Henke M, Alfonsi M, Foa P et al (2011) Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. J Clin Oncol 29:2815–2820PubMedGoogle Scholar
  33. Jackson SM, Hay JH, Flores AD et al (1999) Cancer of the tonsil: the results of ipsilateral radiation treatment. Radiother Oncol 51:123–128PubMedGoogle Scholar
  34. Jansen EP, Keus RB, Hilgers FJ et al (2000) Does the combination of radiotherapy and debulking surgery favor survival in paranasal sinus carcinoma? Int J Radiat Oncol Biol Phys 48:27–35PubMedGoogle Scholar
  35. Jiang GL, Ang KK, Peters LJ et al (1991) Maxillary sinus carcinomas: natural history and results of postoperative radiotherapy. Radiother Oncol 21:193–200PubMedGoogle Scholar
  36. Johnson JT, Ferretti GA, Nethery WJ et al (1993) Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 329:390–395PubMedGoogle Scholar
  37. Kaczmar JM, Tan KS, Heitjan DF et al (2016) HPV-related oropharyngeal cancer: risk factors for treatment failure in patients managed with primary transoral robotic surgery. Head Neck 38:59–65PubMedGoogle Scholar
  38. Kam MK, Leung SF, Zee B et al (2007) Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25:4873–4879PubMedGoogle Scholar
  39. Kamada T, Tsujii H, Blakely EA et al (2015) Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience. Lancet Oncol 16:e93–e100PubMedGoogle Scholar
  40. Kjems J, Gothelf AB, Hakansson K et al (2016) Elective nodal irradiation and patterns of failure in head and neck cancer after primary radiation therapy. Int J Radiat Oncol Biol Phys 94:775–782PubMedGoogle Scholar
  41. Koh WJ, Laramore G, Griffin T et al (1989) Fast neutron radiation for inoperable and recurrent salivary gland cancers. Am J Clin Oncol 12:316–319PubMedGoogle Scholar
  42. Kong L, Hu J, Guan X et al (2016) Phase I/II trial evaluating carbon ion radiotherapy for salvaging treatment of locally recurrent nasopharyngeal carcinoma. J Cancer 7:774–783PubMedPubMedCentralGoogle Scholar
  43. Kosaki K, Ecker S, Habermehl D et al (2012) Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas. Radiat Oncol 7:44PubMedPubMedCentralGoogle Scholar
  44. Kouvaris JR, Kouloulias VE, Vlahos LJ (2007) Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist 12:738–747PubMedGoogle Scholar
  45. Laramore GE, Krall JM, Griffin TW et al (1993) Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an rtog-mrc randomized clinical trial. Radiation therapy oncology group. Medical research council. Int J Radiat Oncol Biol Phys 27:235–240PubMedGoogle Scholar
  46. Le QT, Kim HE, Schneider CJ et al (2011) Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. J Clin Oncol 29:2808–2814PubMedGoogle Scholar
  47. Lefebvre JL, Andry G, Chevalier D et al (2012) Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891. Ann Oncol 23:2708–2714PubMedPubMedCentralGoogle Scholar
  48. LeVeque FG, Montgomery M, Potter D et al (1993) A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 11:1124–1131PubMedGoogle Scholar
  49. Lewis GD, Holliday EB, Kocak-Uzel E et al (2016) Intensity-modulated proton therapy for nasopharyngeal carcinoma: decreased radiation dose to normal structures and encouraging clinical outcomes. Head Neck 38(Suppl 1):E1886–E1895PubMedGoogle Scholar
  50. Lin R, Slater JD, Yonemoto LT et al (1999) Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy: dose-volume histogram analysis. Radiology 213:489–494PubMedGoogle Scholar
  51. Locher JL, Bonner JA, Carroll WR et al (2011) Prophylactic percutaneous endoscopic gastrostomy tube placement in treatment of head and neck cancer: a comprehensive review and call for evidence-based medicine. JPEN J Parenter Enteral Nutr 35:365–374PubMedGoogle Scholar
  52. Marx RE (1983) Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 41:283–288PubMedGoogle Scholar
  53. Marx RE, Johnson RP, Kline SN (1985) Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc 111:49–54PubMedGoogle Scholar
  54. Meng Z, Garcia MK, Hu C et al (2012) Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma. Cancer 118:3337–3344PubMedGoogle Scholar
  55. Mizoe JE, Tsujii H, Kamada T et al (2004) Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 60:358–364PubMedGoogle Scholar
  56. Mizoe JE, Hasegawa A, Jingu K et al (2012) Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol 103:32–37PubMedGoogle Scholar
  57. Munzenrider JE, Liebsch NJ (1999) Proton therapy for tumors of the skull base. Strahlenther Onkol 175(Suppl 2):57–63PubMedGoogle Scholar
  58. Murdoch-Kinch CA, Kim HM, Vineberg KA et al (2008) Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 72:373–382PubMedPubMedCentralGoogle Scholar
  59. Murthy AK, Hendrickson FR (1980) Is contralateral neck treatment necessary in early carcinoma of the tonsil? Int J Radiat Oncol Biol Phys 6:91–94PubMedGoogle Scholar
  60. Myers LL, Nussenbaum B, Bradford CR et al (2002) Paranasal sinus malignancies: an 18-year single institution experience. Laryngoscope 112:1964–1969PubMedGoogle Scholar
  61. Noel G, Feuvret L, Calugaru V et al (2005) Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncol 44:700–708PubMedGoogle Scholar
  62. Nutting CM, Morden JP, Harrington KJ et al (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (parsport): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12:127–136PubMedPubMedCentralGoogle Scholar
  63. O’Sullivan B, Warde P, Grice B et al (2001) The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 51:332–343PubMedGoogle Scholar
  64. O’Sullivan B, Huang SH, Siu LL et al (2013) Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 31:543–550PubMedGoogle Scholar
  65. Olsen KD (2010) Reexamining the treatment of advanced laryngeal cancer. Head Neck 32:1–7PubMedGoogle Scholar
  66. Patt HM, Tyree EB, Straube RL et al (1949) Cysteine protection against X irradiation. Science (New York, NY) 110:213–214Google Scholar
  67. Pfister DG, Cassileth BR, Deng GE et al (2010) Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol 28:2565–2570PubMedPubMedCentralGoogle Scholar
  68. Pfister DG, Spencer S, Brizel DM et al (2015) Head and neck cancers, version 1.2015. J Natl Compr Cancer Netw 13:847–855. quiz 856Google Scholar
  69. Pohar S, Demarcantonio M, Whiting P et al (2015) Percutaneous endoscopic gastrostomy tube dependence following chemoradiation in head and neck cancer patients. Laryngoscope 125:1366–1371PubMedGoogle Scholar
  70. Pommier P, Liebsch NJ, Deschler DG et al (2006) Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 132:1242–1249PubMedGoogle Scholar
  71. Posner MR, Hershock DM, Blajman CR et al (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705–1715PubMedGoogle Scholar
  72. Rasey JS, Krohn KA, Menard TW et al (1986) Comparative biodistribution and radioprotection studies with three radioprotective drugs in mouse tumors. Int J Radiat Oncol Biol Phys 12:1487–1490PubMedGoogle Scholar
  73. Resto VA, Chan AW, Deschler DG et al (2008) Extent of surgery in the management of locally advanced sinonasal malignancies. Head Neck 30:222–229PubMedGoogle Scholar
  74. Rieken S, Habermehl D, Nikoghosyan A et al (2011) Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique. Int J Radiat Oncol Biol Phys 81:e793–e801PubMedGoogle Scholar
  75. Rombi B, Ares C, Hug EB et al (2013) Spot-scanning proton radiation therapy for pediatric chordoma and chondrosarcoma: clinical outcome of 26 patients treated at Paul Scherrer Institute. Int J Radiat Oncol Biol Phys 86:578–584PubMedGoogle Scholar
  76. Rosenzweig KE, Sim SE, Mychalczak B et al (2001) Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 50:681–685PubMedGoogle Scholar
  77. Rudat V, Munter M, Rades D et al (2008) The effect of amifostine or imrt to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy. Radiother Oncol 89:71–80PubMedGoogle Scholar
  78. Rutz HP, Weber DC, Goitein G et al (2008) Postoperative spot-scanning proton radiation therapy for chordoma and chondrosarcoma in children and adolescents: initial experience at Paul Scherrer Institute. Int J Radiat Oncol Biol Phys 71:220–225PubMedGoogle Scholar
  79. Salas S, Baumstarck-Barrau K, Alfonsi M et al (2009) Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: prospective randomized trial. Radiother Oncol 93:503–509PubMedGoogle Scholar
  80. Schmid E, Schlegel D, Guldbakke S et al (2003) RBE of nearly monoenergetic neutrons at energies of 36 keV-14.6 MeV for induction of dicentrics in human lymphocytes. Radiat Environ Biophys 42:87–94PubMedGoogle Scholar
  81. Schulz-Ertner D, Nikoghosyan A, Jakel O et al (2003) Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas. Int J Radiat Oncol Biol Phys 56:391–398PubMedGoogle Scholar
  82. Setton J, Lee NY, Riaz N et al (2015) A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy. Cancer 121:294–301PubMedGoogle Scholar
  83. Shaw R, Forner L, Butterworth C et al (2011) Randomised controlled trials in HBO: “a call to arms” for HOPON & DAHANCA-21. Br J Oral Maxillofac Surg 49:76–77PubMedGoogle Scholar
  84. Stiff PJ, Emmanouilides C, Bensinger WI et al (2006) Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting. J Clin Oncol 24:5186–5193PubMedGoogle Scholar
  85. Vacha P, Fehlauer F, Mahlmann B et al (2003) Randomized phase iii trial of postoperative radiochemotherapy +/– amifostine in head and neck cancer. Is there evidence for radioprotection? Strahlenther Onkol 179:385–389PubMedGoogle Scholar
  86. Villaflor VM, Melotek JM, Karrison TG et al (2016) Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer. Ann Oncol 27:908–913PubMedGoogle Scholar
  87. Vlashi E, Chen AM, Boyrie S et al (2016) Radiation-induced dedifferentiation of head and neck cancer cells into cancer stem cells depends on human papillomavirus status. Int J Radiat Oncol Biol Phys 94:1198–1206PubMedPubMedCentralGoogle Scholar
  88. Wolf GT, Hong WK, Fisher SG, Urba S, Endicott JW, Fisher SR, Toohill RJ, Karp D, Miller DM, Cheung NK, Weaver A, Hillel AD, Spauldine M, Chang BK, Dougherty B, Deconti R, Garewal H, Fye C (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The department of veterans affairs laryngeal cancer study group. N Engl J Med 324:1685–1690PubMedGoogle Scholar
  89. Yang WF, Liao GQ, Hakim SG et al (2016) Is pilocarpine effective in preventing radiation-induced xerostomia? A systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 94:503–511PubMedGoogle Scholar
  90. Yeung AR, Garg MK, Lawson J et al (2012) ACR appropriateness criteria(r) ipsilateral radiation for squamous cell carcinoma of the tonsil. Head Neck 34:613–616PubMedGoogle Scholar
  91. Zorlu F, Gurkaynak M, Yildiz F et al (2000) Conventional external radiotherapy in the management of clivus chordomas with overt residual disease. Neurol Sci 21:203–207PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • D. A. Elliott
    • 1
    • 2
  • N. Nabavizadeh
    • 1
  • K. Hiluf
    • 1
  • J. M. Holland
    • 1
    Email author
  1. 1.Department of Radiation OncologyOregon Health and Science UniversityPortlandUSA
  2. 2.Department of Radiation OncologyEleanor N. Dana Cancer Center, University of ToledoToledoUSA

Personalised recommendations